China Jo-Jo Drugstores (NASDAQ:CJJD) and Express Scripts (NASDAQ:ESRX) are both retail/wholesale companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.
This is a summary of current ratings and recommmendations for China Jo-Jo Drugstores and Express Scripts, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|China Jo-Jo Drugstores||0||0||0||0||N/A|
Express Scripts has a consensus target price of $96.08, suggesting a potential upside of 4.07%. Given Express Scripts’ higher possible upside, analysts clearly believe Express Scripts is more favorable than China Jo-Jo Drugstores.
Earnings & Valuation
This table compares China Jo-Jo Drugstores and Express Scripts’ revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|China Jo-Jo Drugstores||$107.55 million||0.32||-$930,000.00||N/A||N/A|
|Express Scripts||$100.06 billion||0.52||$4.52 billion||$7.10||13.00|
Express Scripts has higher revenue and earnings than China Jo-Jo Drugstores.
Volatility & Risk
China Jo-Jo Drugstores has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500. Comparatively, Express Scripts has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500.
This table compares China Jo-Jo Drugstores and Express Scripts’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|China Jo-Jo Drugstores||-2.37%||-15.04%||-3.67%|
Institutional and Insider Ownership
18.2% of China Jo-Jo Drugstores shares are held by institutional investors. Comparatively, 84.9% of Express Scripts shares are held by institutional investors. 31.3% of China Jo-Jo Drugstores shares are held by company insiders. Comparatively, 0.8% of Express Scripts shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Express Scripts beats China Jo-Jo Drugstores on 10 of the 11 factors compared between the two stocks.
About China Jo-Jo Drugstores
China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM onsite for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates dada360.com, an online drugstore that retails OTC drugs and nutritional supplements. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2018, it had 122 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as operates 9 drugstores under the Jiuzhou Grand Pharmacy name in Zhejiang Province. China Jo-Jo Drugstores, Inc. is headquartered in Hangzhou, the People's Republic of China.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.
Receive News & Ratings for China Jo-Jo Drugstores Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Jo-Jo Drugstores and related companies with MarketBeat.com's FREE daily email newsletter.